Sökning: (WFRF:(Schmieder Roland E)) srt2:(2020-2023) >
Arteriovenous fistu...
Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortar in haemodialysis patients from the AURORA trial
-
- Girerd, Sophie (författare)
- Univ Hosp, Dept Nephrol, Nancy, France.;Lorraine Univ, Univ Hosp, Ctr Invest Clin Plurithemat, INSERM, Nancy, France.;F CRIN INI CRCT, Nancy, France.
-
- Girerd, Nicolas (författare)
- Lorraine Univ, Univ Hosp, Ctr Invest Clin Plurithemat, INSERM, Nancy, France.;F CRIN INI CRCT, Nancy, France.
-
- Frimat, Luc (författare)
- Univ Hosp, Dept Nephrol, Nancy, France.;F CRIN INI CRCT, Nancy, France.
-
visa fler...
-
- Holdaas, Hallvard (författare)
- Univ Oslo, Rikshosp, Med Dept, Oslo, Norway.
-
- Jardine, Alan G. (författare)
- Univ Glasgow, British Heart Fdn Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Renal Res Grp, Glasgow, Lanark, Scotland.
-
- Schmieder, Roland E. (författare)
- Univ Hosp Erlangen, Dept Nephrol & Hypertens, Erlangen, Germany.
-
- Fellström, Bengt, 1947- (författare)
- Uppsala universitet,Njurmedicin
-
- Settembre, Nicla (författare)
- Univ Hosp, Dept Vasc Surg, Nancy, France.
-
- Malikov, Sergei (författare)
- Univ Hosp, Dept Vasc Surg, Nancy, France.
-
- Rossignol, Patrick (författare)
- Lorraine Univ, Univ Hosp, Ctr Invest Clin Plurithemat, INSERM, Nancy, France.;F CRIN INI CRCT, Nancy, France.
-
- Zannad, Faiez (författare)
- Lorraine Univ, Univ Hosp, Ctr Invest Clin Plurithemat, INSERM, Nancy, France.;F CRIN INI CRCT, Nancy, France.
-
visa färre...
-
Univ Hosp, Dept Nephrol, Nancy, France;Lorraine Univ, Univ Hosp, Ctr Invest Clin Plurithemat, INSERM, Nancy, France.;F CRIN INI CRCT, Nancy, France. Lorraine Univ, Univ Hosp, Ctr Invest Clin Plurithemat, INSERM, Nancy, France.;F CRIN INI CRCT, Nancy, France. (creator_code:org_t)
- 2019-05-11
- 2020
- Engelska.
-
Ingår i: Clinical Kidney Journal. - : Oxford University Press (OUP). - 2048-8505 .- 2048-8513. ; 13:1, s. 116-122
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://academic.oup...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background. The impact of arteriovenous fistula (AVF) or graft (AVG) thrombosis on mortality has been sparsely studied. This study investigated the association between AVF/AVG thrombosis and all-cause and cardiovascular mortality.Methods. The data from 2439 patients with AVF or AVG undergoing maintenance haemodialysis (HD) included in the A Study to Evaluate the Use of Rosuvastatin in Subjects on Regular Hemodialysis: An Assessment of Survival and Cardiovascular Events trial (AURORA) were analysed using a time-dependent Cox model. The incidence of vascular access (VA) thrombosis was a pre-specified secondary outcome.Results. During follow-up, 278 AVF and 94 AVG thromboses were documented. VA was restored at 22 +/- 64 days after thrombosis (27 patients had no restoration with subsequent permanent central catheter). In multivariable survival analysis adjusted for potential confounders, the occurrence of AVF/AVG thrombosis was associated with increased early and late allcause mortality, with a more pronounced association with early all-cause mortality {hazard ratio [HR] < 90 days 2.70 [95% confidence interval (CI) 1.83-3.97], P < 0.001; HR > 90 days 1.47 [1.20-1.80], P < 0.001). In addition, the occurrence of AVF thrombosis was significantly associated with higher all-cause mortality, whether VA was restored within 7 days [HR 1.34 (95% CI 1.02-1.75), P = 0.036] or later than 7 days [HR 1.81 (95% CI 1.29-2.53), P = 0.001].Conclusions. AVF/AVG thrombosis should be considered as a major clinical event since it is strongly associated with increased mortality in patients on maintenance HD, especially in the first 90 days after the event and when access restoration occurs >7 days after thrombosis. Clinicians should pay particular attention to the timing of VA restoration and the management of these patients during this high-risk period. The potential benefit of targeting overall patient risk with more aggressive treatment after AVF/AVG restoration should be further explored.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Urology and Nephrology (hsv//eng)
Nyckelord
- arteriovenous fistula
- arteriovenous graft
- cardiovascular mortality
- chronic haemodialysis
- survival
- vascular access complication
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Girerd, Sophie
-
Girerd, Nicolas
-
Frimat, Luc
-
Holdaas, Hallvar ...
-
Jardine, Alan G.
-
Schmieder, Rolan ...
-
visa fler...
-
Fellström, Bengt ...
-
Settembre, Nicla
-
Malikov, Sergei
-
Rossignol, Patri ...
-
Zannad, Faiez
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Urologi och njur ...
- Artiklar i publikationen
-
Clinical Kidney ...
- Av lärosätet
-
Uppsala universitet